{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Is Dynatronics Corp. overvalued or undervalued?
As of October 1, 2023, Dynatronics Corp. is considered an attractive investment due to its undervalued financial metrics, including a P/E ratio of 12.5 and a P/B ratio of 1.2, which compare favorably to peers like Medtronic and Stryker Corp. while also demonstrating positive stock performance relative to the Sensex.
Who are in the management team of Dynatronics Corp.?
As of March 2022, the management team of Dynatronics Corp. includes Erin Enright (Independent Chairman), John Krier (CEO and Director), Brian Baker (Director), and several Independent Directors: David Holtz, Scott Klosterman, Brian Larkin, and R. Scott Ward. They guide the company's strategic direction and governance.
What does Dynatronics Corp. do?
Dynatronics Corporation is a micro-cap manufacturer and distributor of physical medicine products in the Pharmaceuticals & Biotechnology industry, with recent net sales of $6 million and a net profit of -$1 million. The company has a market cap of $0.94 million and a debt equity ratio of 0.25.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
